Filter your results
- 3
- 1
- 2
- 2
- 4
- 1
- 3
- 4
- 4
- 4
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Drug-induced liver injury in obesity and nonalcoholic fatty liver diseaseAdvances in Pharmacology, Academic Press Inc., pp.75-107, 2019, ⟨10.1016/bs.apha.2019.01.003⟩
Book sections
hal-02051781v1
|
||
|
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver DiseaseInternational Journal of Molecular Sciences, 2022, 23 (3), pp.1062. ⟨10.3390/ijms23031062⟩
Journal articles
hal-03557349v1
|
||
Mitochondrial dysfunction induced by xenobiotics Involvement in steatosis and steatohepatitisMitochondria in Obesity and Type 2 Diabetes - Comprehensive Review on Mitochondrial Functioning and Involvement in Metabolic Diseases, Elsevier, pp.347-364, 2019, 9780128117521; 9780128118597. ⟨10.1016/B978-0-12-811752-1.00015-8⟩
Book sections
hal-02569993v1
|
|||
Importance of non-mitochondrial pathways in drug-induced hepatic steatosis: investigations with 12 steatotic drugs in HepaRG cellsToxicology Letters, 2019, 314, pp.S60-S60
Journal articles
hal-02310684v1
|